METHOD AND SYSTEM FOR DECISION SUPPORT IN PHARMACEUTICAL PRICING
Existing approaches in pharmaceutical pricing, fail to provide visibility on nature of pricing followed by pharma players such as pharmacy benefit managers (PBMs), manufacturer, distributor, insurer, and so on, due to involvement of many players in pharma value chain and their complicated pricing st...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Existing approaches in pharmaceutical pricing, fail to provide visibility on nature of pricing followed by pharma players such as pharmacy benefit managers (PBMs), manufacturer, distributor, insurer, and so on, due to involvement of many players in pharma value chain and their complicated pricing strategies. The disclosure herein generally relates to decision support system for pharmaceutical pricing, and, more particularly, to a method and system for providing visibility on nature of pricing followed by different entities of pharma players. The system, by performing pricing analysis, extracts a magnitude of interrelationship between the plurality of entities in the pharmaceutical domain to form a pharmaceutical pricing guide. The pharmaceutical pricing guide is further processed to maximize a measured quality of the pharmaceutical pricing guide in real time and used to choose entities of pharma players associated with retail pharmacy. |
---|